Task Specific vs Basketball-Based Balance Training in Children With Developmental Delay
Launched by SHALAMAR INSTITUTE OF HEALTH SCIENCES · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two types of balance training for children who have developmental delay (DD). The study will focus on how task-specific balance training and basketball-based training can help improve balance and motor skills in children aged 5 to 12. Researchers want to find out which type of training might be more effective in helping these children move and balance better.
To participate in this study, children must be between 5 and 12 years old, have a diagnosis of developmental delay, and be able to follow instructions. The trial is open to both boys and girls, but children with certain conditions—like serious neurological issues, physical deformities, or visual and hearing impairments—won't be eligible. If your child participates, they will be involved in activities designed to improve their balance and motor skills, and this could be a fun way for them to learn and grow. The trial is not yet recruiting, so there’s time to consider the opportunity before it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 5-12
- • Diagnosed with DD
- • Able to follow instruction
- • Male and female are included
- Exclusion Criteria:
- • • Neurological conditions other than DD
- • Musculoskeletal deformities
- • Visual or hearing impairments
- • Participants who are unable to engage in the assigned interventions due to physical or cognitive limitations
About Shalamar Institute Of Health Sciences
Shalamar Institute of Health Sciences is a leading healthcare organization dedicated to advancing medical research and clinical trials. With a commitment to improving patient outcomes and enhancing healthcare practices, the institute collaborates with a diverse array of stakeholders, including healthcare professionals, researchers, and regulatory bodies. By fostering innovation and adhering to the highest ethical standards, Shalamar Institute of Health Sciences aims to contribute significantly to the scientific community and the development of new therapeutic interventions. Its state-of-the-art facilities and experienced team provide a robust environment for conducting rigorous clinical trials that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported